| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | -0.43 | 0.01 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.36 | 0.0006 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | -0.35 | 0.05 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | -0.35 | 0.04 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.34 | 0.05 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.33 | 0.009 |
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | -0.29 | 0.02 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.27 | 0.03 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.23 | 8e-12 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | -0.23 | 0.09 |